All PBCs were invasive ductal carcinomas, the pathological grade was high (grade 2–3), 29% of tumors were estrogen receptor (ER)-negative, 50% were progesterone receptor (PR)-negative, and 21% were ERBB2-positive. The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.